全文获取类型
收费全文 | 454篇 |
免费 | 16篇 |
国内免费 | 53篇 |
出版年
2023年 | 6篇 |
2022年 | 12篇 |
2021年 | 11篇 |
2020年 | 11篇 |
2019年 | 16篇 |
2018年 | 14篇 |
2017年 | 14篇 |
2016年 | 22篇 |
2015年 | 29篇 |
2014年 | 26篇 |
2013年 | 46篇 |
2012年 | 65篇 |
2011年 | 27篇 |
2010年 | 26篇 |
2009年 | 13篇 |
2008年 | 27篇 |
2007年 | 17篇 |
2006年 | 23篇 |
2005年 | 21篇 |
2004年 | 14篇 |
2003年 | 24篇 |
2002年 | 12篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1999年 | 6篇 |
1998年 | 5篇 |
1997年 | 5篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1994年 | 9篇 |
1993年 | 4篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1988年 | 2篇 |
1986年 | 2篇 |
排序方式: 共有523条查询结果,搜索用时 93 毫秒
521.
Postpartum Levothyroxine Adjustment and Its Impact Factors in Women With Hypothyroidism in Pregnancy
Xiaotong Gao Aihua Liu Xichang Wang Yutong Han Haoyu Wang Jiashu Li Yuanyuan Hou Yang Yang Huiru Wang Chenyu Zhang Weiping Teng Zhongyan Shan 《Endocrine practice》2022,28(6):578-585
ObjectiveWomen with hypothyroidism need to increase exogenous thyroid hormone levels during pregnancy to reduce adverse outcomes. Few studies have reported the effect of gestational levothyroxine (LT4) variations on postpartum LT4 treatment.MethodsWomen were classified as having subclinical hypothyroidism (SCH) (n = 101), overt hypothyroidism (OH) caused by autoimmune thyroiditis (AIT-OH), OH following thyroidectomy for benign thyroid disease (BA-OH) (n = 66), and OH after surgery for papillary thyroid cancer (PTC-OH) (n = 46). Thyroid function was monitored, and LT4 therapy was adjusted accordingly.ResultsAfter delivery, all women with SCH stopped LT4 treatment, and 57.4% of them restarted LT4 treatment in the following 1 year, independently of the gestational LT4 variations. Among patients with OH, after adjusted by gestational body weight, 49.1% of them had LT4 doses less than the prepregnancy dose (baseline) in late pregnancy, leading to LT4 reduction in postpartum. The LT4 dose was reduced to approximately 50% baseline for women with AIT-OH and BA-OH and reduced by 27% for women with PTC-OH. The reduction reasons for AIT-OH and BA-OH were thyroid-stimulating hormone levels of <2.5 mU/L during pregnancy and postpartum thyrotoxicosis occurrence (39.4%), and for PTC-OH, the reason was thyroid-stimulating hormone overinhibition (<1.0 mU/L) before delivery.ConclusionFor patients with SCH, postpartum LT4 treatment could initially be suspended. For women with OH, if the LT4 dose in late pregnancy was less than baseline, a prepregnancy dose reduced by 50%, 50%, and 27% should be applied after delivery for women with AIT-OH, BA-OH, and PTC-OH, respectively. 相似文献
522.
523.
Yanyan Zhao Ying Liang Yuan Liu Xiao Zhang Xiaodan Hu Sicong Tu Aihua Wu Cunzheng Zhang Jianfeng Zhong Shengming Zhao Xianjin Liu Kang Tu 《Analytical biochemistry》2016
An antibody to phenoxybenzoic acid (PBA), the conserved chemical region of pyrethroids, was developed using a domain antibody (DAB) library to enable pyrethroid detection in agricultural products. The DAB library, constructed without animal immunization and based on a human VH framework, displayed repertoires on filamentous bacteriophage. After four rounds of panning, we obtained five domain antibodies that are capable of binding to PBA. Antibody A3 has strong identification capability to cypermethrin, β-cypermethrin, and fenvalerate. The antibody A3 was used to develop an enzyme-linked immunosorbent assay (ELISA). The IC50 values were 2.586, 1.814, and 2.251 μg/ml for cypermethrin, β-cypermethrin, and fenvalerate, respectively. The assay shows weak competition with flucythrinate but shows no competition with fenpropathrin, deltamethrin, and permethrin. The developed ELISA process was successfully applied to fortified Chinese cabbage samples, with the recoveries of cypermethrin, β-cypermethrin, and fenvalerate ranging from 84.4 to 112.3%. We developed an immunoassay to detect pyrethroids depending on the domain antibody library, which overcomes the limitation of requiring protein antigen to immunize animals raising antibody. 相似文献